These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 1779334

  • 1. Urinary dopamine/noradrenaline and dopamine/vanillylmandelic acid ratios as a reflection of different biology of adrenergic clones in children's neuroblastic tumors.
    Izbicki T, Bozek J, Perek D, Wozniak W.
    J Pediatr Surg; 1991 Oct; 26(10):1230-4. PubMed ID: 1779334
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Urinary excretion of methylated catecholamine metabolites in a child with neuroblastoma maturing into ganglioneuroma.
    Candito M, Soler C, Deville A, Bekri S, Chambon P, Thyss A.
    Med Pediatr Oncol; 1996 Jan; 26(1):57-60. PubMed ID: 7494513
    [Abstract] [Full Text] [Related]

  • 5. The relationship between homovanillic/vanillylmandelic acid ratios and prognosis in neuroblastoma.
    Nishi M, Miyake H, Takeda T, Hanai J, Fujita K, Ichimiya H, Tanaka T, Hirama T, Ishikawa Y, Kudoh T, Azuma H, Takase A.
    Oncol Rep; 1998 Jan; 5(3):631-3. PubMed ID: 9538165
    [Abstract] [Full Text] [Related]

  • 6. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
    Nakagawara A, Zaizen Y, Ikeda K, Suita S, Ohgami H, Nagahara N, Sera Y, Akiyama H, Kawakami K, Uchino J.
    Cancer; 1991 Nov 01; 68(9):2037-44. PubMed ID: 1913552
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dopaminergic neuroblastoma as a poor prognostic subgroup.
    Nakagawara A, Ikeda K, Tasaka H.
    J Pediatr Surg; 1988 Apr 01; 23(4):346-9. PubMed ID: 3385588
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma.
    Laug WE, Siegel SE, Shaw KN, Landing B, Baptista J, Gutenstein M.
    Pediatrics; 1978 Jul 01; 62(1):77-83. PubMed ID: 683787
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Catecholamine excretion in children with neurogenic tumors of the mediastinum].
    Stepanov EA, Bukhny AE, Bol'shakova TD, Lukicheva TI.
    Khirurgiia (Mosk); 1972 Jun 01; 48(6):125-8. PubMed ID: 5043043
    [No Abstract] [Full Text] [Related]

  • 15. Urinary VMA, dopamine and the likelihood of neuroblastoma: a preferred way of reporting laboratory results?
    Sies CW, Florkowski CM, Sullivan M, Mackay R, George PM.
    Ann Clin Biochem; 2006 Jul 01; 43(Pt 4):300-5. PubMed ID: 16824281
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Suppression of norepinephrine secretion by dopamine in children with neuroblastoma: evidence for precursor inhibition in catecholamine pathway.
    Sato T, Minami S, Igarashi N, Miyagawa K.
    Endocrinol Jpn; 1989 Aug 01; 36(4):595-603. PubMed ID: 2583066
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.